Quick Takeaways
- Ron Squarer has 4 issuer positions tracked on this page.
- Estimated disclosed ownership value: $1,223,787.
- Recent insider filing activity is available below.
- Info
- Insider Ownership
Insider Trading & Ownership of Ron Squarer
- Location
- San Diego, CA
- Summary
- The estimated net worth of Ron Squarer is at least $1,223,787 dollars as of 11 Dec 2025. Ron Squarer is the Director of Travere Therapeutics, Inc. and owns shares of Travere Therapeutics, Inc. (TVTX) stock worth about $648.4K. Ron Squarer is the Director of ADC Therapeutics SA and owns shares of ADC Therapeutics SA (ADCT) stock worth about $335.2K. Ron Squarer is the Director of Nuvalent, Inc. and owns shares of Nuvalent, Inc. (NUVL) stock worth about $240.2K.
- Signature
- /s/ Nathan N. McConarty, attorney-in-fact
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Ron Squarer and return when a new Insider Trading filing appears.
This tracks SEC filing changes for this page using existing product update flows.
What Changed
- Largest disclosed position: Travere Therapeutics, Inc. ($648,423).
- Past-year value change for that position: .
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Official SEC Source
Filed on Form 4
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
See Original FilingOwnership of Ron Squarer
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| TVTX | Travere Therapeutics, Inc. | Director | $648,423 | 15 May 2025 | ||
| ADCT | ADC Therapeutics SA | Director | $335,184 | 13 Jun 2025 | ||
| NUVL | Nuvalent, Inc. | Director | $240,180 | 10 Dec 2025 | ||
| Deciphera Pharmaceuticals, Inc. | Director | $0 | 11 Jun 2024 |
Insider Transactions Reported by Ron Squarer:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.